Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The New York Times – Business:

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

This post first appeared in The New York Times – Business. Read the original article.